The debt of Cellebrite DI Ltd. over the past 7 years
Chart Cellebrite DI Ltd.: liquid cash, total debt, net cash, fiscal 2019–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, Cellebrite DI Ltd. had liquid cash of $437.05M and total debt of $0: net cash of $437.05M. It had more liquid cash than debt at all 6 year-ends shown.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $437.05M* | $0 | $437.05M |
| 2024ended Dec 31, 2024 | $447.22M* | $0 | $447.22M |
| 2023ended Dec 31, 2023 | $38.69M | $0 | $38.69M |
| 2022ended Dec 31, 2022 | $44.64M | $0 | $44.64M |
| 2021ended Dec 31, 2021 | $181.56M* | $0 | $181.56M |
| 2020ended Dec 31, 2020 | $237.64M* | $0 | $237.64M |
| 2019ended Dec 31, 2019 | — | — | — |
Fiscal years as Cellebrite DI Ltd. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Cellebrite DI Ltd.
- The revenue of Cellebrite DI Ltd.
- The profitability of Cellebrite DI Ltd.
- The cash flow of Cellebrite DI Ltd.
- All of Cellebrite DI Ltd.'s financials, charted
Companies of a similar size
- KNFKnife River Corporation
- AMLXAmylyx Pharmaceuticals, Inc.
- EEFTEURONET WORLDWIDE, INC.
- IMAXIMAX Corporation
- PFSPROVIDENT FINANCIAL SERVICES INC
Not investment advice. This page shows what Cellebrite DI Ltd. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.